Literature DB >> 27334407

A polar ring endows improved specificity to an antibody fragment.

Zachary P Schaefer1, Lucas J Bailey1, Anthony A Kossiakoff1.   

Abstract

Engineering monovalent Fab fragments into bivalent formats like IgGs or F(ab')2 can lead to aggregation presumably because of nonspecific off-target interactions that induce aggregation. In an effort to further understand the molecular determinants of nonspecific interactions for engineered antibodies and natively folded proteins in general, we focused on a synthetic Fab with low nanomolar affinity to histone chaperone Anti-silencing factor 1 (Asf1) that demonstrates off-target binding through low solubility (∼5 mg/mL) in the multivalent F(ab') 2 state. Here, we generated phage display-based shotgun scanning libraries to introduce aspartate as a negative design element into the antibody paratope. The antibody-combining site was amenable to aspartate substitution at numerous positions within the antigen binding loops and one variant, Tyr(L93) Asp/His(L94) Asp/Thr(H100b) Asp, possessed high solubility (>100 mg/ml). Furthermore, the mutations decreased nonspecific interactions measured by column interaction chromatography and ELISA in the multivalent antibody format while maintaining high affinity to the antigen. Structural determination of the antibody-antigen complex revealed that the aspartate-permissive residues formed a polar ring around the structural and functional paratope, recapitulating the canonical feature of naturally occurring protein-protein interactions. This observation may inform future strategies for the design and engineering of molecular recognition.
© 2016 The Protein Society.

Entities:  

Keywords:  antibody engineering; phage display; protein engineering; protein solubility

Mesh:

Substances:

Year:  2016        PMID: 27334407      PMCID: PMC4918417          DOI: 10.1002/pro.2888

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  39 in total

Review 1.  Engineering aggregation-resistant antibodies.

Authors:  Joseph M Perchiacca; Peter M Tessier
Journal:  Annu Rev Chem Biomol Eng       Date:  2012-03-29       Impact factor: 11.059

2.  Transfer of engineered biophysical properties between different antibody formats and expression systems.

Authors:  Jonas V Schaefer; Andreas Plückthun
Journal:  Protein Eng Des Sel       Date:  2012-07-04       Impact factor: 1.650

3.  Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis.

Authors:  R Blake Pepinsky; Laura Silvian; Steven A Berkowitz; Graham Farrington; Alexey Lugovskoy; Lee Walus; John Eldredge; Allan Capili; Sha Mi; Christilyn Graff; Ellen Garber
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

4.  Analysis of protein-protein interaction sites using surface patches.

Authors:  S Jones; J M Thornton
Journal:  J Mol Biol       Date:  1997-09-12       Impact factor: 5.469

5.  Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions.

Authors:  Joseph M Perchiacca; Ali Reza A Ladiwala; Moumita Bhattacharya; Peter M Tessier
Journal:  Protein Eng Des Sel       Date:  2012-07-27       Impact factor: 1.650

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 7.  Principles of protein-protein interactions.

Authors:  S Jones; J M Thornton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

10.  Towards automated crystallographic structure refinement with phenix.refine.

Authors:  Pavel V Afonine; Ralf W Grosse-Kunstleve; Nathaniel Echols; Jeffrey J Headd; Nigel W Moriarty; Marat Mustyakimov; Thomas C Terwilliger; Alexandre Urzhumtsev; Peter H Zwart; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-03-16
View more
  5 in total

1.  An engineered ultra-high affinity Fab-Protein G pair enables a modular antibody platform with multifunctional capability.

Authors:  Tomasz Slezak; Lucas J Bailey; Mateusz Jaskolowski; Dominik A Nahotko; Ekaterina V Filippova; Elena K Davydova; Anthony A Kossiakoff
Journal:  Protein Sci       Date:  2019-11-01       Impact factor: 6.725

2.  Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity.

Authors:  Yulei Zhang; Lina Wu; Priyanka Gupta; Alec A Desai; Matthew D Smith; Lilia A Rabia; Seth D Ludwig; Peter M Tessier
Journal:  Mol Pharm       Date:  2020-06-11       Impact factor: 4.939

3.  Rapid Discovery and Characterization of Synthetic Neutralizing Antibodies against Anthrax Edema Toxin.

Authors:  Mara Farcasanu; Andrew G Wang; Tomasz Uchański; Lucas J Bailey; Jiping Yue; Zhaochun Chen; Xiaoyang Wu; Anthony Kossiakoff; Wei-Jen Tang
Journal:  Biochemistry       Date:  2019-06-19       Impact factor: 3.162

Review 4.  Protein Engineering: Advances in Phage Display for Basic Science and Medical Research.

Authors:  Elena K Davydova
Journal:  Biochemistry (Mosc)       Date:  2022-01       Impact factor: 2.487

Review 5.  Toward Drug-Like Multispecific Antibodies by Design.

Authors:  Manali S Sawant; Craig N Streu; Lina Wu; Peter M Tessier
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.